Mesenchymal stem cell culture amplification medium and preparation method thereof
By adding oxygen sustained-release materials and natural extracts to mesenchymal stem cell culture medium, the problem of cell aging and contamination risks is solved, and a longer growth cycle and higher proliferation rate is achieved, meeting the needs of clinical applications.
Patent Information
- Application Number
- CN202411441703.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-16
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-10-16
Smart Images

Figure HDA0005086508020000011 
Figure HDA0005086508020000012 
Figure HDA0005086508020000013
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of cell culture, and in particular to a mesenchymal stem cell culture and expansion medium and a preparation method thereof. Background Art
[0002] Mesenchymal stem cells (MSC) are a type of multipotent stem cell with a certain differentiation potential. They can differentiate into a variety of cell types, such as skeletal muscle, myocardium, fat, cartilage, and bone. They are used in clinical practice to replace target cell populations and repair damaged and diseased tissues and organs. They have immunomodulatory functions and can play the role of immune reconstruction. Allogeneic transplant rejection is relatively mild, and the requirements for matching are not strict, so they are widely used. Mesenchymal stem cells are mainly found in the bone marrow, and can also be separated and prepared from tissues such as fat, synovium, bone, muscle, lung, liver, pancreas, as well as amniotic fluid and umbilical cord blood. After isolating human mesenchymal stem cells, human mesenchymal stem cells need to be cultured to a sufficient amount for differentiation into target tissues. Differentiation potential also needs to be maintained during the culture process. When mesenchymal stem cells are cultured with traditional cell culture medium (DMEM+10% FBS), the cells will show obvious aging characteristics by the third generation. In addition, the culture system of stem cells mainly uses culture medium containing animal serum (such as fetal bovine serum). The heterologous contamination brought by animal serum and the contamination of known or unknown viruses, mycoplasma and other pathogens, the changes in the internal structure of stem cells grown in such an environment are unknown, which brings potential risks to the clinical research of MSCs. The commercialized serum-free culture medium for MSCs on the market is expensive, and the cell growth cycle is short, the cell proliferation effect is not ideal, the cell senescence is fast, and the cell proliferation rate and multidirectional differentiation ability are reduced. Summary of the invention
[0003] In view of the deficiencies in the prior art, the present invention provides a mesenchymal stem cell culture and expansion medium and a preparation method thereof.
[0004] The present invention is achieved through the following technical solutions:
[0005] A mesenchymal stem cell culture and expansion medium uses a DMEM / F12 medium as a basic component, wherein the DMEM / F12 medium further comprises the following components: 8 g / L of oxygen sustained-release material, 2 g / L of natural extract, 30 ng / mL of growth factor, 5 mM of nicotinamide, 8 μg / mL of cholesterol, 20 mg / L of recombinant human transferrin, 10 mg / L of recombinant human insulin, 4 mg / L of vitamin C, 2 mM of L-glutamine, 60 μg / L of reduced glutathione, and 20 mg / L of sodium selenite.
[0006] Furthermore, the growth factors are basic fibroblast growth factor 10 ng / mL, transforming growth factor-β 10 ng / mL and platelet-derived growth factor-BB 10 ng / mL.
[0007] Furthermore, the preparation method of the oxygen slow-release material comprises the following steps:
[0008] (1) preparing a 0.1 mol / L sodium carbonate aqueous solution, a 0.1 mol / L calcium chloride aqueous solution, a 10 mmol / L sodium dodecyl sulfate aqueous solution, and a 2 g / L tartaric acid aqueous solution; dividing the tartaric acid aqueous solution into two equal volumes, pouring them into the sodium carbonate solution and the calcium chloride solution, respectively, and stirring at 60° C. and 200-300 rpm for 18-25 min to obtain a mixed solution A and a mixed solution B, respectively;
[0009] (2) Pour the sodium dodecyl sulfate aqueous solution of step (1) into the mixed solution A obtained in step (1), react in a water bath at 80° C. for 20-30 min, add the mixed solution B obtained in step (1), continue to react in a water bath for 0.8-1.2 h, maintain the stirring speed at 200 r / min, centrifuge at 5000 rpm for 10 min to collect the precipitate, wash with deionized water and anhydrous ethanol, and dry at 60° C. to obtain porous nanoparticles;
[0010] (3) placing the porous nanoparticles obtained in step (2) in a reaction kettle and evacuating the vacuum, and when the pressure in the reaction kettle is constant, stopping the evacuation and filling with oxygen, and when the pressure in the reaction kettle reaches 0.35 MPa, stopping the filling with oxygen, and obtaining oxygen-carrying porous nanoparticles;
[0011] (4) adding γ-cyclodextrin, malic acid, and sodium hypophosphite to deionized water, ultrasonically treating at 300-400W for 30 minutes, reacting at 100°C for 3 hours, reacting at 140°C for 10-15 minutes, adding distilled water and stirring evenly, adding anhydrous ethanol and standing at 4°C for 3-4 hours, centrifuging at 8000 rpm for 5 minutes, washing the precipitate with anhydrous ethanol, and vacuum drying at 50°C to obtain malic acid-cyclodextrin;
[0012] (5) Add the malic acid-cyclodextrin, resveratrol and aminosulfonic acid obtained in step (4) to benzene, stir at 100 rpm, heat and reflux at 100-110° C. for 5-6 h, vacuum filter while hot, let the filtrate stand at 4-6° C. for 3-4 h, centrifuge at 5000 rpm for 15-20 min, recrystallize the precipitate with ethyl acetate, wash with anhydrous ethanol, and dry in vacuo at 60° C. to obtain modified cyclodextrin;
[0013] (6) Add the modified cyclodextrin obtained in step (5) into deionized water, stir at 30° C. and 180 rpm for 30 min to obtain a modified cyclodextrin solution; add the modified cyclodextrin solution into the reactor described in step (3), stir at 40-60° C. and 100-150 rpm for 2-3 h, let stand at 4° C. for 2 h, centrifuge at 8000-10000 rpm for 5-8 min, wash the precipitate with anhydrous ethanol and deionized water, and vacuum dry to obtain an oxygen sustained-release material.
[0014] Furthermore, in step (1), the volume ratio of the prepared sodium carbonate aqueous solution, calcium chloride aqueous solution, sodium dodecyl sulfate aqueous solution and tartaric acid aqueous solution is 2:2:1:1.
[0015] Furthermore, in step (4), the usage ratio of γ-cyclodextrin, malic acid, sodium hypophosphite and deionized water is 1 g: 1 g: 0.6-0.8 g: 20 mL.
[0016] Furthermore, in step (4), the volume ratio of distilled water to deionized water is 1:4.
[0017] Furthermore, in step (4), the volume ratio of the added anhydrous ethanol to distilled water is 10-12:1.
[0018] Furthermore, in step (5), the dosage ratio of malic acid-cyclodextrin, resveratrol, aminosulfonic acid and benzene is 1 g:1.2-1.5 g:0.05 g:10-12 mL.
[0019] Furthermore, in step (6), the dosage ratio of the modified cyclodextrin to deionized water is 1 g:5-7 mL.
[0020] Furthermore, in step (6), the mass ratio of the modified cyclodextrin solution to the oxygen-carrying porous nanoparticles in the reactor is 5:1.
[0021] Furthermore, the preparation method of the natural extract comprises the following steps: drying astragalus and dandelion at 100°C, grinding through a 100-mesh sieve to obtain a mixed powder; taking the mixed powder, adding 10 times the weight of deionized water, heating at 100°C for 1 hour, filtering to obtain a filtrate, extracting three times, combining the filtrate, and heating at 60°C, 10 -3 MPa was concentrated to 20% of the original volume, 95 vol% ethanol solution was added to the final ethanol concentration of 60 wt%, and the mixture was allowed to stand at 4°C for 6-8 h, centrifuged at 5000 rpm for 30 min, the supernatant was filtered through a 0.22 μm filter membrane, and freeze-dried at -20°C for 20-24 h to obtain a natural extract.
[0022] Furthermore, the mass ratio of dandelion to astragalus is 1:1.
[0023] Furthermore, the present invention also provides a method for preparing the mesenchymal stem cell culture expansion medium, comprising the following steps: filtering the DMEM / F12 medium through a 0.22 μm filter membrane, adding oxygen sustained-release material, natural extracts, growth factors, nicotinamide, cholesterol, recombinant human transferrin, recombinant human insulin, vitamin C, L-glutamine, reduced glutathione, and sodium selenite, and stirring at 180 rpm for 30-40 min to obtain a mesenchymal stem cell culture expansion medium.
[0024] Furthermore, the mesenchymal stem cells are umbilical cord mesenchymal stem cells, umbilical cord blood mesenchymal stem cells, adipose mesenchymal stem cells, bone marrow mesenchymal stem cells or placental mesenchymal stem cells.
[0025] Furthermore, the mesenchymal stem cells are preferably umbilical cord mesenchymal stem cells.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] The invention prepares an oxygen slow-release material with an oxygen slow-release function. The pores of porous nanoparticles are used as oxygen carriers and pure oxygen is used as an oxygen source. When used, no strong oxidizing and alkaline substances are generated, which is beneficial to the growth and reproduction of cells. At the same time, a coating layer is used to slowly release oxygen, and the dissolved oxygen added to the culture medium can be maintained at a certain level to continuously provide oxygen to the cells. After the oxygen slow-release material releases oxygen, the pores of the porous medium can also effectively adsorb impurities in the culture medium to reduce the risk of cell contamination. The oxygen slow-release material of the invention uses modified cyclodextrin as a raw material for the coating layer. The cyclodextrin can be biodegraded, provides nutrients, and promotes cell proliferation. The oxygen slow-release material can provide continuous oxygen support for mesenchymal stem cells, maintain the metabolic needs of the cells, maintain the normal metabolic activities of the mesenchymal stem cells by providing continuous oxygen, avoid stress reactions caused by hypoxia, and can be used for long-term slow release of oxygen to avoid oxidative stress reactions and improve cell survival rates. The present invention can improve the antioxidant activity, help cells maintain activity, improve dispersibility, and at the same time, the modified group can appropriately reduce the hole entrance size, so that the hole size can be suitable for porous nanoparticles loaded with oxygen, improve the recognition ability of cyclodextrin, reduce the de-inclusion phenomenon caused by the slightly larger molecular hole size of γ-cyclodextrin, effectively improve stability, enhance oxygen slow-release performance, and facilitate the amplification and growth of mesenchymal stem cells. The present invention adds astragalus and dandelion extracts, including compounds such as polysaccharides and flavonoids, has antioxidant properties, can protect cells from ROS damage, maintain cell metabolism stability, ensure the efficiency of energy utilization, and astragalus and dandelion extracts can synergize, improve cell growth environment, and promote the growth and proliferation of mesenchymal stem cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only for the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0029] Figure 1 This is a microscope image of umbilical cord mesenchymal stem cells of generation P10 of Example 1 and the control group described in Experimental Example 1 of the present invention;
[0030] Figure 2 The growth curve of mesenchymal stem cells cultured in the culture medium described in Example 2 of the present invention and Comparative Examples 1-3;
[0031] Figure 3 The graph is a graph showing changes in oxygen concentration when mesenchymal stem cells are cultured in the culture medium described in Example 3 of the present invention and Comparative Example 2. DETAILED DESCRIPTION
[0032] In order to make the purpose, technical scheme and advantages of the present invention more clear, the present invention is further described in detail below in conjunction with specific embodiments, but the present invention is not limited to the following embodiments. It should be noted that, unless otherwise specified, the chemical reagents involved in the present invention are purchased through commercial channels.
[0033] Example 1: This example provides a mesenchymal stem cell culture and expansion medium, which uses DMEM / F12 medium as a basic component, and the DMEM / F12 medium also includes the following components: 8 g / L of oxygen sustained-release material, 2 g / L of natural extract, 30 ng / mL of growth factor, 5 mM of nicotinamide, 8 μg / mL of cholesterol, 20 mg / L of recombinant human transferrin, 10 mg / L of recombinant human insulin, 4 mg / L of vitamin C, 2 mM of L-glutamine, 60 μg / L of reduced glutathione, and 20 mg / L of sodium selenite.
[0034] Growth factors were basic fibroblast growth factor 10 ng / mL, transforming growth factor-β 10 ng / mL, and platelet-derived growth factor-BB 10 ng / mL.
[0035] The preparation method of the oxygen slow-release material comprises the following steps:
[0036] (1) preparing 100 mL of a 0.1 mol / L sodium carbonate aqueous solution, 100 mL of a 0.1 mol / L calcium chloride aqueous solution, 50 mL of a 10 mmol / L sodium dodecyl sulfate aqueous solution, and 50 mL of a 2 g / L tartaric acid aqueous solution; dividing the tartaric acid aqueous solution into two 25 mL portions, respectively pouring them into the sodium carbonate solution and the calcium chloride solution, stirring at 60° C. and 300 rpm for 25 min, to obtain a mixed solution A and a mixed solution B, respectively;
[0037] (2) Pour the sodium dodecyl sulfate aqueous solution of step (1) into the mixed solution A obtained in step (1), react in a water bath at 80° C. for 30 min, add the mixed solution B obtained in step (1), continue to react in a water bath for 1.2 h, maintain the stirring speed at 200 r / min, collect the precipitate by centrifugation at 5000 rpm for 10 min, wash with deionized water and anhydrous ethanol, and dry at 60° C. to obtain porous nanoparticles;
[0038] (3) placing the porous nanoparticles obtained in step (2) in a reaction kettle and evacuating the vacuum, and when the pressure in the reaction kettle is constant, stopping the evacuation and filling with oxygen, and when the pressure in the reaction kettle reaches 0.35 MPa, stopping the filling with oxygen, and obtaining oxygen-carrying porous nanoparticles;
[0039] (4) 10 g of γ-cyclodextrin, 10 g of malic acid, and 8 g of sodium hypophosphite were added to 200 mL of deionized water, ultrasonicated at 400 W for 30 min, reacted at 100 ° C for 3 h, reacted at 140 ° C for 15 min, added 50 mL of distilled water and stirred evenly, added 600 mL of anhydrous ethanol and allowed to stand at 4 ° C for 4 h, centrifuged at 8000 rpm for 5 min, washed the precipitate with anhydrous ethanol, and vacuum dried at 50 ° C to obtain malic acid-cyclodextrin;
[0040] (5) Add 10 g of malic acid-cyclodextrin, 15 g of resveratrol and 0.5 g of aminosulfonic acid obtained in step (4) to 120 mL of benzene, stir at 100 rpm, heat at reflux at 110° C. for 6 h, vacuum filter while hot, let the filtrate stand at 6° C. for 4 h, centrifuge at 5000 rpm for 20 min, recrystallize the precipitate with ethyl acetate, wash with anhydrous ethanol, and dry in vacuo at 60° C. to obtain modified cyclodextrin;
[0041] (6) Add 20 g of the modified cyclodextrin obtained in step (5) to 140 mL of deionized water, and stir at 30° C. and 180 rpm for 30 min to obtain a modified cyclodextrin solution; add the modified cyclodextrin solution to the reactor described in step (3), with the mass ratio of the modified cyclodextrin solution to the oxygen-carrying porous nanoparticles in the reactor being 5:1, stir at 60° C. and 150 rpm for 3 h, let stand at 4° C. for 2 h, centrifuge at 10,000 rpm for 8 min, wash the precipitate with anhydrous ethanol and deionized water, and dry in vacuo to obtain an oxygen sustained-release material.
[0042] The preparation method of the natural extract comprises the following steps: drying 10g of astragalus and 10g of dandelion at 100°C, grinding and passing through a 100-mesh sieve to obtain a mixed powder; taking the mixed powder, adding 10 times the weight of deionized water, heating and extracting at 100°C for 1h, filtering to obtain a filtrate, extracting three times, combining the filtrate, and simmering at 60°C, 10 -3 MPa was concentrated to 20% of the original volume, 95 vol% ethanol solution was added to the final ethanol concentration of 60 wt%, and the mixture was allowed to stand at 4°C for 8 h, centrifuged at 5000 rpm for 30 min, the supernatant was filtered through a 0.22 μm filter membrane, and freeze-dried at -20°C for 24 h to obtain a natural extract.
[0043] This embodiment also provides a method for preparing the mesenchymal stem cell culture expansion medium, comprising the following steps: filtering the DMEM / F12 medium through a 0.22 μm filter membrane, adding oxygen sustained-release material, natural extracts, growth factors, nicotinamide, cholesterol, recombinant human transferrin, recombinant human insulin, vitamin C, L-glutamine, reduced glutathione, and sodium selenite, and stirring at 180 rpm for 40 min to obtain a mesenchymal stem cell culture expansion medium.
[0044] Example 2: This example provides a mesenchymal stem cell culture and expansion medium, which uses DMEM / F12 medium as a basic component, and the DMEM / F12 medium also includes the following components: 8 g / L of oxygen sustained-release material, 2 g / L of natural extract, 30 ng / mL of growth factor, 5 mM of nicotinamide, 8 μg / mL of cholesterol, 20 mg / L of recombinant human transferrin, 10 mg / L of recombinant human insulin, 4 mg / L of vitamin C, 2 mM of L-glutamine, 60 μg / L of reduced glutathione, and 20 mg / L of sodium selenite.
[0045] Growth factors were basic fibroblast growth factor 10 ng / mL, transforming growth factor-β 10 ng / mL, and platelet-derived growth factor-BB 10 ng / mL.
[0046] The preparation method of the oxygen slow-release material comprises the following steps:
[0047] (1) preparing 100 mL of a 0.1 mol / L sodium carbonate aqueous solution, 100 mL of a 0.1 mol / L calcium chloride aqueous solution, 50 mL of a 10 mmol / L sodium dodecyl sulfate aqueous solution, and 50 mL of a 2 g / L tartaric acid aqueous solution; dividing the tartaric acid aqueous solution into two 25 mL portions, respectively pouring them into the sodium carbonate solution and the calcium chloride solution, stirring at 60° C. and 200 rpm for 18 min, to obtain a mixed solution A and a mixed solution B, respectively;
[0048] (2) Pour the sodium dodecyl sulfate aqueous solution of step (1) into the mixed solution A obtained in step (1), react in a water bath at 80° C. for 20 min, add the mixed solution B obtained in step (1), continue to react in a water bath for 0.8 h, maintain the stirring speed at 200 r / min, collect the precipitate by centrifugation at 5000 rpm for 10 min, wash with deionized water and anhydrous ethanol, and dry at 60° C. to obtain porous nanoparticles;
[0049] (3) placing the porous nanoparticles obtained in step (2) in a reaction kettle and evacuating the vacuum, and when the pressure in the reaction kettle is constant, stopping the evacuation and filling with oxygen, and when the pressure in the reaction kettle reaches 0.35 MPa, stopping the filling with oxygen, and obtaining oxygen-carrying porous nanoparticles;
[0050] (4) 10 g of γ-cyclodextrin, 10 g of malic acid, and 6 g of sodium hypophosphite were added to 200 mL of deionized water, ultrasonicated at 300 W for 30 min, reacted at 100 ° C for 3 h, reacted at 140 ° C for 10 min, added 50 mL of distilled water and stirred evenly, added 500 mL of anhydrous ethanol and allowed to stand at 4 ° C for 3 h, centrifuged at 8000 rpm for 5 min, washed the precipitate with anhydrous ethanol, and vacuum dried at 50 ° C to obtain malic acid-cyclodextrin;
[0051] (5) Add 10 g of malic acid-cyclodextrin, 12 g of resveratrol and 0.5 g of aminosulfonic acid obtained in step (4) to 100 mL of benzene, stir at 100 rpm, heat at reflux at 100° C. for 5 h, vacuum filter while hot, let the filtrate stand at 4° C. for 3 h, centrifuge at 5000 rpm for 15 min, recrystallize the precipitate with ethyl acetate, wash with anhydrous ethanol, and dry in vacuo at 60° C. to obtain modified cyclodextrin;
[0052] (6) Add 20 g of the modified cyclodextrin obtained in step (5) to 100 mL of deionized water, and stir at 30° C. and 180 rpm for 30 min to obtain a modified cyclodextrin solution; add the modified cyclodextrin solution to the reactor described in step (3), with the mass ratio of the modified cyclodextrin solution to the oxygen-carrying porous nanoparticles in the reactor being 5:1, stir at 40° C. and 100 rpm for 2 h, let stand at 4° C. for 2 h, centrifuge at 8000 rpm for 5 min, wash the precipitate with anhydrous ethanol and deionized water, and vacuum dry to obtain an oxygen sustained-release material.
[0053] The preparation method of the natural extract comprises the following steps: drying 10g of astragalus and 10g of dandelion at 100°C, grinding and passing through a 100-mesh sieve to obtain a mixed powder; taking the mixed powder, adding 10 times the weight of deionized water, heating and extracting at 100°C for 1h, filtering to obtain a filtrate, extracting three times, combining the filtrate, and simmering at 60°C, 10 -3MPa was concentrated to 20% of the original volume, 95 vol% ethanol solution was added to the final ethanol concentration of 60 wt%, and the mixture was allowed to stand at 4°C for 6 h, centrifuged at 5000 rpm for 30 min, the supernatant was filtered through a 0.22 μm filter membrane, and freeze-dried at -20°C for 20 h to obtain a natural extract.
[0054] This embodiment also provides a method for preparing the mesenchymal stem cell culture expansion medium, comprising the following steps: filtering the DMEM / F12 medium through a 0.22 μm filter membrane, adding oxygen sustained-release material, natural extracts, growth factors, nicotinamide, cholesterol, recombinant human transferrin, recombinant human insulin, vitamin C, L-glutamine, reduced glutathione, and sodium selenite, and stirring at 180 rpm for 30 min to obtain a mesenchymal stem cell culture expansion medium.
[0055] Example 3: This example provides a mesenchymal stem cell culture and expansion medium, which uses DMEM / F12 medium as a basic component, and the DMEM / F12 medium also includes the following components: 8 g / L of oxygen sustained-release material, 2 g / L of natural extract, 30 ng / mL of growth factor, 5 mM of nicotinamide, 8 μg / mL of cholesterol, 20 mg / L of recombinant human transferrin, 10 mg / L of recombinant human insulin, 4 mg / L of vitamin C, 2 mM of L-glutamine, 60 μg / L of reduced glutathione, and 20 mg / L of sodium selenite.
[0056] Growth factors were basic fibroblast growth factor 10 ng / mL, transforming growth factor-β 10 ng / mL, and platelet-derived growth factor-BB 10 ng / mL.
[0057] The preparation method of the oxygen slow-release material comprises the following steps:
[0058] (1) preparing 100 mL of a 0.1 mol / L sodium carbonate aqueous solution, 100 mL of a 0.1 mol / L calcium chloride aqueous solution, 50 mL of a 10 mmol / L sodium dodecyl sulfate aqueous solution, and 50 mL of a 2 g / L tartaric acid aqueous solution; dividing the tartaric acid aqueous solution into two 25 mL portions, respectively pouring them into the sodium carbonate solution and the calcium chloride solution, stirring at 60° C. and 250 rpm for 20 min, to obtain a mixed solution A and a mixed solution B, respectively;
[0059] (2) Pour the sodium dodecyl sulfate aqueous solution of step (1) into the mixed solution A obtained in step (1), react in a water bath at 80° C. for 25 min, add the mixed solution B obtained in step (1), continue to react in a water bath for 1 h, maintain the stirring speed at 200 r / min, centrifuge at 5000 rpm for 10 min to collect the precipitate, wash with deionized water and anhydrous ethanol, and dry at 60° C. to obtain porous nanoparticles;
[0060] (3) placing the porous nanoparticles obtained in step (2) in a reaction kettle and evacuating the vacuum, and when the pressure in the reaction kettle is constant, stopping the evacuation and filling with oxygen, and when the pressure in the reaction kettle reaches 0.35 MPa, stopping the filling with oxygen, and obtaining oxygen-carrying porous nanoparticles;
[0061] (4) 10 g of γ-cyclodextrin, 10 g of malic acid, and 7 g of sodium hypophosphite were added to 200 mL of deionized water, ultrasonicated at 350 W for 30 min, reacted at 100 ° C for 3 h, reacted at 140 ° C for 12 min, added 50 mL of distilled water and stirred evenly, added 550 mL of anhydrous ethanol and allowed to stand at 4 ° C for 3.5 h, centrifuged at 8000 rpm for 5 min, washed the precipitate with anhydrous ethanol, and vacuum dried at 50 ° C to obtain malic acid-cyclodextrin;
[0062] (5) Add 10 g of malic acid-cyclodextrin, 13 g of resveratrol and 0.5 g of aminosulfonic acid obtained in step (4) to 110 mL of benzene, stir at 100 rpm, heat under reflux at 105° C. for 5.5 h, vacuum filter while hot, let the filtrate stand at 5° C. for 3.5 h, centrifuge at 5000 rpm for 18 min, recrystallize the precipitate with ethyl acetate, wash with anhydrous ethanol, and dry in vacuo at 60° C. to obtain modified cyclodextrin;
[0063] (6) Add 20 g of the modified cyclodextrin obtained in step (5) to 120 mL of deionized water, and stir at 30° C. and 180 rpm for 30 min to obtain a modified cyclodextrin solution; add the modified cyclodextrin solution to the reactor described in step (3), with the mass ratio of the modified cyclodextrin solution to the oxygen-carrying porous nanoparticles in the reactor being 5:1, stir at 50° C. and 120 rpm for 2.5 h, let stand at 4° C. for 2 h, centrifuge at 9000 rpm for 6 min, wash the precipitate with anhydrous ethanol and deionized water, and dry in vacuo to obtain an oxygen sustained-release material.
[0064] The preparation method of the natural extract comprises the following steps: drying 10g of astragalus and 10g of dandelion at 100°C, grinding and passing through a 100-mesh sieve to obtain a mixed powder; taking the mixed powder, adding 10 times the weight of deionized water, heating and extracting at 100°C for 1h, filtering to obtain a filtrate, extracting three times, combining the filtrate, and simmering at 60°C, 10 -3 MPa was concentrated to 20% of the original volume, 95 vol% ethanol solution was added to the final ethanol concentration of 60 wt%, and the mixture was allowed to stand at 4°C for 7 h, centrifuged at 5000 rpm for 30 min, the supernatant was filtered through a 0.22 μm filter membrane, and freeze-dried at -20°C for 22 h to obtain a natural extract.
[0065] This embodiment also provides a method for preparing the mesenchymal stem cell culture expansion medium, comprising the following steps: filtering the DMEM / F12 medium through a 0.22 μm filter membrane, adding oxygen sustained-release material, natural extracts, growth factors, nicotinamide, cholesterol, recombinant human transferrin, recombinant human insulin, vitamin C, L-glutamine, reduced glutathione, and sodium selenite, and stirring at 180 rpm for 35 minutes to obtain a mesenchymal stem cell culture expansion medium.
[0066] The only difference between Comparative Example 1 and Example 1 is that no oxygen slow-release material is added.
[0067] The only difference between Comparative Example 2 and Example 1 is that γ-cyclodextrin is used instead of modified cyclodextrin.
[0068] The only difference between Comparative Example 3 and Example 1 is that no natural extract is added.
[0069] Experimental Example 1: The umbilical cord was collected aseptically, with a length of about 10 cm. After being washed 5 times with 0.9% physiological saline, the umbilical cord tissue was mechanically shredded into 2 mm pieces and evenly placed in a 10 cm cell culture dish. The gap between the attached tissue pieces was 5-10 mm. The mesenchymal stem cell culture and expansion medium described in Example 1 was added and cultured in a 37°C, 5% CO2 incubator. The obtained cells were P0 generation cells. The medium was then changed every 3-4 days. After the cell confluence reached 80%, the cells were digested and harvested with Tryspin-EDTA. The cell density was 8000 cells / cm 2 The cells were inoculated and subcultured, and the cells after subculture 1 were P1 cells, and so on, and the cell morphology was observed. DMEM + 10% FBS culture medium was used as the control group.
[0070] When the cells were cultured to P10, photos were taken to record the cell morphology. Figure 1 As shown, Figure 1 The results showed that the cells in the control group increased in volume and showed obvious characteristics of cell senescence, while the cells in the Example 1 group still maintained a good spindle morphology and had no obvious characteristics of cell senescence, indicating that the mesenchymal stem cell expansion culture medium of the present invention is beneficial to the growth and proliferation of mesenchymal stem cells and reduces cell senescence.
[0071] Experimental Example 2: Umbilical cord mesenchymal stem cells P5 from the same source (prepared using the culture medium obtained in Example 2 and Comparative Examples 1-3 according to the method of Experimental Example 1) were adjusted to a cell density of 1×10 4Each well was incubated at 37°C and 5% CO2 for 24, 48, 72, 96, and 168 hours. 10 μL of CCK8 solution was added to each well and the cells were incubated for 3 hours. The OD450 absorbance was read by a microplate reader and the growth curve of the cells in different culture media was plotted. The results are shown in Figure 2. Figure 2 shown.
[0072] Figure 2 The results showed that the cells cultured in Example 2 grew faster, and the number of cells cultured in Example 2 was larger at the same time. The cells in Example 2 proliferated faster and were able to proliferate and pass on stably, while the proliferation of Comparative Examples 1-3 slowed down, indicating that the culture medium of the present invention can promote cell proliferation.
[0073] Experimental Example 3: Umbilical cord mesenchymal stem cells P10 from the same source (prepared using the culture medium obtained in Examples 1-3 and Comparative Examples 1-2 according to the method of Experimental Example 1) were adjusted to a cell density of 1×10 5 / mL, and the cell phenotype was identified by flow cytometry; fluorescein-labeled CD73, CD90, CD105, CD34 and CD45 antibodies and isotype controls were added, incubated at room temperature in the dark for 30 minutes, and the expression of cell surface markers was detected by flow cytometry. The results are shown in Table 1.
[0074] Table 1:
[0075] CD73 (%) CD90(%) CD105(%) CD34 (%) CD45 (%) Example 1 99.41 99.68 99.12 0.081 0.543 Example 2 99.45 99.67 99.18 0.085 0.539 Example 3 99.47 99.62 99.14 0.082 0.543 Comparative Example 1 96.12 96.38 95.15 1.231 1.612 Comparative Example 2 97.42 97.68 97.14 1.011 1.212 Comparative Example 3 96.43 96.68 96.15 1.191 1.498
[0076] The results in Table 1 show that the expression levels of CD73, CD90, and CD105 of the P10 cells cultured with the mesenchymal stem cell expansion medium of the present invention are all ≥95%, and the positive rates of CD45 and CD34 are less than 2%, which is consistent with the phenotypic characteristics of umbilical cord mesenchymal stem cells, showing the properties of umbilical cord mesenchymal stem cells, having the characteristics of MSCs, and having a high purity. Compared with the results of comparative examples 1-3, the flow cytometry results of Examples 1-3 are better.
[0077] Experimental Example 4: Umbilical cord mesenchymal stem cells P3 from the same source (prepared using the culture medium obtained in Example 3 and Comparative Example 2 according to the method of Experimental Example 1) were adjusted to a cell density of 1×10 5 The cells were inoculated into a 12-well plate at 1 mL / well and cultured at 37°C and 5% CO2. The changes in oxygen concentration were measured after 1, 2, 4, 7, and 12 days of culture. The results are as follows: Figure 3 shown.
[0078] Figure 3The results showed that the oxygen concentration in Comparative Example 2 increased significantly after 1 day of culture, and then began to decrease on the 2nd day, while that in Example 3 increased gently and remained at a certain level after 4 days, indicating that the culture medium prepared by the present invention has good stability, the oxygen concentration changes relatively stably, and the overall oxygen concentration is maintained at a certain level, which is conducive to the growth of mesenchymal stem cells.
[0079] Those skilled in the art should understand that the discussion of any of the above embodiments is merely illustrative and is not intended to imply that the scope of the present invention is limited to these examples. Under the concept of the present invention, the technical features in the above embodiments or different embodiments may be combined, the steps may be implemented in any order, and there are many other variations of the different aspects of the present invention as described above, which are not provided in detail for the sake of simplicity.
Claims
1. A mesenchymal stem cell culture and expansion medium, characterized in that: The DMEM / F12 culture medium is used as a basic component, and the DMEM / F12 culture medium also includes the following components: 8 g / L of oxygen slow-release material, 2 g / L of natural extract, 30 ng / mL of growth factor, 5 mM of nicotinamide, 8 μg / mL of cholesterol, 20 mg / L of recombinant human transferrin, 10 mg / L of recombinant human insulin, 4 mg / L of vitamin C, 2 mM of L-glutamine, 60 μg / L of reduced glutathione, and 20 mg / L of sodium selenite; The growth factors are basic fibroblast growth factor, transforming growth factor-β and platelet-derived growth factor-BB; The method for preparing the natural extract comprises the following steps: drying and grinding astragalus and dandelion to obtain a mixed powder; taking the mixed powder, adding deionized water, heating for extraction, filtering, concentrating under reduced pressure, adding an ethanol solution, standing, centrifuging, filtering the supernatant, and freeze-drying to obtain the natural extract; The mass ratio of dandelion to astragalus is 1:1; The preparation method of the oxygen slow-release material comprises the following steps: (1) preparing a 0.1 mol / L sodium carbonate aqueous solution, a 0.1 mol / L calcium chloride aqueous solution, a 10 mmol / L sodium dodecyl sulfate aqueous solution, and a 2 g / L tartaric acid aqueous solution; dividing the tartaric acid aqueous solution into two equal volumes, pouring the two into the sodium carbonate solution and the calcium chloride solution, respectively, and stirring to obtain a mixed solution A and a mixed solution B, respectively; (2) pouring the sodium dodecyl sulfate aqueous solution obtained in step (1) into the mixed solution A obtained in step (1), reacting, adding the mixed solution B obtained in step (1), continuing the reaction, centrifuging, washing the precipitate, and drying to obtain porous nanoparticles; (3) placing the porous nanoparticles obtained in step (2) in a reaction kettle, evacuating the air, and filling the reactor with oxygen to obtain oxygen-carrying porous nanoparticles; (4) adding γ-cyclodextrin, malic acid, and sodium hypophosphite to deionized water, ultrasonicating, reacting at 100° C., reacting at 140° C., adding distilled water, adding anhydrous ethanol, standing, centrifuging, washing the precipitate, and drying to obtain malic acid-cyclodextrin; (5) adding the malic acid-cyclodextrin, resveratrol and aminosulfonic acid obtained in step (4) to benzene, stirring, heating to reflux, filtering with suction, letting the filtrate stand, centrifuging, recrystallizing the precipitate with ethyl acetate, washing, and drying to obtain modified cyclodextrin; (6) adding the modified cyclodextrin obtained in step (5) into deionized water and stirring to obtain a modified cyclodextrin solution; adding the modified cyclodextrin solution into the reaction kettle described in step (3), stirring, standing, centrifuging, washing the precipitate, and drying to obtain an oxygen sustained-release material.
2. The mesenchymal stem cell culture and expansion medium according to claim 1, characterized in that In step (1), the volume ratio of the sodium carbonate aqueous solution, the calcium chloride aqueous solution, the sodium dodecyl sulfate aqueous solution and the tartaric acid aqueous solution is 2:2:1:
1.
3. The mesenchymal stem cell culture and expansion medium according to claim 2, characterized in that: In step (4), the dosage ratio of γ-cyclodextrin, malic acid, sodium hypophosphite and deionized water is 1g:1g:0.6-0.8g:20mL; the volume ratio of distilled water to deionized water is 1:4; and the volume ratio of the added anhydrous ethanol to distilled water is 10-12:
1.
4. The mesenchymal stem cell culture and expansion medium according to claim 3, characterized in that: In step (5), the dosage ratio of malic acid-cyclodextrin, resveratrol, aminosulfonic acid and benzene is 1g:1.2-1.5g:0.05g:10-12mL.
5. The mesenchymal stem cell culture and expansion medium according to claim 4, characterized in that: In step (6), the dosage ratio of the modified cyclodextrin to deionized water is 1 g:5-7 mL; the mass ratio of the modified cyclodextrin solution to the oxygen-carrying porous nanoparticles in the reactor is 5:
1.
6. The mesenchymal stem cell culture and expansion medium according to claim 5, characterized in that: The mesenchymal stem cells are umbilical cord mesenchymal stem cells.
7. A method for preparing a mesenchymal stem cell culture and expansion medium according to any one of claims 1 to 6, characterized in that: The following steps are involved: The DMEM / F12 medium is filtered, and oxygen sustained-release materials, natural extracts, growth factors, nicotinamide, cholesterol, recombinant human transferrin, recombinant human insulin, vitamin C, L-glutamine, reduced glutathione, and sodium selenite are added and stirred to obtain a mesenchymal stem cell culture and expansion medium.
Citation Information
Patent Citations
Oxygen slow-release hydrogel as well as preparation method and application thereof
CN115887780A
Mesenchymal stem cells conditioned medium and methods of generating and using the same
WO2013121427A1
Cited By
Culture medium and culture method for preparing umbilical cord mesenchymal stem cell exosome
CN120829871A
